
Clearside Biomedical
A biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases.
Market cap
$30.4m
Enterprise value
$22m
Share price
$0.39 CLSD
Authorizing premium user...